3,3'-Diindolylmethane in Patients With Systemic Lupus Erythematosus

NCT02483624 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

SLE

Interventions

DRUG: BR-DIM
DRUG: Placebo

Sponsor

Northwell Health